BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Clarus Therapeutics Touts Phase 3 Success for Oral Testosterone Replacement Therapy

  September 25, 2012

   · 

  2 min read
• Deals

  Rosemont Pharmaceuticals Ltd. Put Up for Sale With £200 Million Price Tag

  September 25, 2012

   · 

  1 min read
• Drug Development

  Immune Response BioPharma Release: REMUNE Effectiveness Extends Years After Inoculation REMUNE Patient Has 2 Healthy HIV Free Children

  September 25, 2012

   · 

  2 min read
• Drug Development

  Cold Spring Harbor Laboratory Scientists Use Cancer Drugs to Reverse Alzheimer’s-Like Memory Loss in 2 Animal Models

  September 25, 2012

   · 

  1 min read
• Business

  Sony to Fling $642 Million at Scandal-Hit Olympus Corporation

  September 25, 2012

   · 

  1 min read
• Deals

  MedCath Corporation Dissolving Company

  September 25, 2012

   · 

  1 min read
• FDA

  Advanced Brain Monitoring, Inc.'s Sleep Profiler™ Cleared by FDA for Neuro-Cardio Assessment of Sleep Quality

  September 25, 2012

   · 

  2 min read
• Policy

  Southern California Medical Device Maker Dallen Medical Files for FDA Clearance

  September 25, 2012

   · 

  1 min read
• Policy

  Covidien plc Forebear Tyco International Ltd. Pays $26 Million to Settle Overseas Bribery Beef

  September 25, 2012

   · 

  1 min read
• Genetown

  Vertex Pharmaceuticals (MA) Ends Work on One Hepatitis C Drug, Continues Another

  September 25, 2012

   · 

  11 min read